Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: Effect of angiotensin-converting enzyme and vasopeptidase inhibition
- C. Wihler
- , S. Schäfer
- , K. Schmid
- , E. K. Deemer
- , G. Münch
- , M. Bleich
- , A. E. Busch
- , T. Dingermann
- , V. Somoza
- , J. W. Baynes
- , J. Huber*
*Corresponding author for this work
- Aventis Pharma Germany GmbH
- University of South Carolina
- James Cook University
- Christian-Albrecht University of Kiel
- Goethe University Frankfurt
Research output: Contribution to journal › Article › peer-review
42
Scopus
citations